Health service utilization by people with psychosis during Peru’s mental health reform and the COVID-19 pandemic: a population-based study.

Publication date: Sep 01, 2026

Individuals with psychosis face persistent barriers to care. Peru’s recent mental health reform expanded services nationwide but coincided with the COVID-19 pandemic. We hypothesized that service utilization among individuals with psychosis would increase between 2018 and 2024, particularly in underserved regions. We analyzed outpatient morbidity data from the Peruvian National Superintendence of Health (2018-2024). Sex was available as binary male/female coding; gender identity and race/ethnicity data were not available. Service utilization was compared across three groups: psychosis, non-psychotic mental disorders, and general medical conditions. We examined changes in access (rate ratios, rate differences), the impact of the pandemic (interrupted time series), and decentralization trends (Poisson regression), separately for each disorder group. In 2024 compared with 2018, monthly service utilization per 100,000 declined for psychosis (28. 2 in 2018-19. 2 in 2024; rate ratio 0. 68), rose for non-psychotic mental disorders (225. 2 in 2018-304. 6 in 2024; 1. 35), and slightly fell for general medical conditions (12,688. 1 in 2018-12,370. 4 in 2024; 0. 97). The pandemic caused a comparable immediate drop in service utilization, with rates falling to 37. 9%, 37. 0%, and 35. 3% of expected levels for the three groups in March 2020, followed by gradual monthly increases (psychosis 1. 3%, non-psychotic mental disorders 2. 6%, general medical conditions 2. 2%). A shift from tertiary to primary and regional facilities was seen for both mental disorder groups, but greater utilization in underserved regions was observed only for non-psychotic mental disorders. Despite nationwide expansion of mental health services, individuals with psychosis did not experience higher service use. The pandemic’s impact was acute and enduring for this group. Findings underscore the need to examine reasons for this stagnation in service utilization and evaluate the acceptability and appropriateness of Peru’s current service model for psychosis. Canadian Institutes of Health Research, Canada Research Chairs program.

Open Access PDF

Concepts Keywords
Big data
Mental health services
Peru (MeSH)
Psychotic disorders
Schizophrenia

Semantics

Type Source Name
disease MESH psychosis
disease MESH COVID-19 pandemic
disease MESH face
disease MESH mental disorders
disease MESH Schizophrenia
drug DRUGBANK Coenzyme M
disease MESH included
drug DRUGBANK Trestolone
disease MESH syndromes
disease MESH anxiety
disease MESH ICD
disease MESH burn

Original Article

(Visited 9 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *